Codexis CDXS
NASDAQ CDXS
$1.59 +0.01 (+0.63%)
As of: Aug 21, 2026 · 10:59 AM EDT

Codexis (CDXS) FCF Margin (2010 - 2026)

Codexis (CDXS) posted quarterly FCF Margin of 90.2% for Q1 2026, up 10936.0% year-over-year from N/an in Q1 2025, and down 321.7% quarter-over-quarter from 40.69% in Q4 2025.

Codexis (CDXS) FCF Margin (2010 - 2026) Analysis & Trends

Codexis' FCF Margin history runs 17 years deep, the most recent figure standing at 90.2% for Q1 2026.

  • In Q1 2026, FCF Margin rose 10936.0% year-over-year to 90.2%; the TTM figure through Mar 2026 stood at 28.87% (up 9127.0% YoY), while the FY2025 annual figure was 33.88%, up 5663.0% from the prior year.
  • FCF Margin for Q1 2026 stood at 90.2%, down from 40.69% in the prior quarter.
  • The five-year high for FCF Margin was 62.42% in Q4 2022, with the low at 353.36% in Q2 2023.
  • The 5-year median for FCF Margin is 91.24% (2024), against an average of 98.25%.
  • The sharpest annual moves came in 2023 and 2024: FCF Margin plunged 36834 bps in 2023, then surged 21028 bps in 2024.
  • Codexis' FCF Margin stood at 62.42% in 2022, then plunged by 590 bps to 305.92% in 2023, then surged by 69 bps to 95.64% in 2024, then jumped by 143 bps to 40.69% in 2025, then sank by 322 bps to 90.2% in 2026.
  • Business Quant data shows CDXS's FCF Margin at 90.2% in Q1 2026, 40.69% in Q4 2025, and 91.47% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Vertex Pharmaceuticals 139.96 Bn 132.11 Bn 2.84 Bn 30.39%
2 Regeneron Pharmaceuticals 86.79 Bn 78.79 Bn 3.93 Bn 13.35%
3 Argenx Se 65.22 Bn 60.03 Bn 1.37 Bn -
4 Moderna 60.20 Bn 55.06 Bn 52.00 Mn -388.28%
5 BeOne Medicines 42.19 Bn 37.09 Bn 1.53 Bn 25.68%
6 Alnylam Pharmaceuticals 31.43 Bn 28.12 Bn 992.69 Mn 22.62%
7 BioNTech SE 28.65 Bn 10.26 Bn 668.28 Mn 41.07%
8 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -22.35%
9 Royalty Pharma 27.16 Bn 26.32 Bn - 70.82%
10 Codexis 144.77 Mn 89.86 Mn 11.40 Mn -67.80%

Historic Data

Download Data
DateValue
Jun 30, 2026 -67.80%
Mar 31, 2026 -90.20%
Dec 31, 2025 40.69%
Sep 30, 2025 -91.47%
Jun 30, 2025 -109.34%
Mar 31, 2025 -199.56%
Dec 31, 2024 -95.64%
Sep 30, 2024 -91.24%
Jun 30, 2024 -157.45%
Mar 31, 2024 -52.24%
Dec 31, 2023 -305.92%
Sep 30, 2023 -133.03%
Jun 30, 2023 -353.36%
Mar 31, 2023 -90.52%
Dec 31, 2022 62.42%
Sep 30, 2022 53.45%
Jun 30, 2022 -10.73%
Mar 31, 2022 -46.05%
Dec 31, 2021 -19.67%
Sep 30, 2021 -22.31%